Healthpeak Properties, Inc. $DOC Shares Sold by Algert Global LLC

Key Points

• Algert Global LLC has reduced its stake in Healthpeak Properties, Inc. by 12.0%, now holding 186,170 shares valued at approximately $3.76 million.
• Insider transactions revealed that CEO Scott M. Brinker and Director Tommy G. Thompson increased their positions in the company, showcasing confidence in Healthpeak Properties amid recent market fluctuations.
• Healthpeak Properties recently announced a dividend of $0.1017 per share, reflecting a yield of 705.0%, with a high dividend payout ratio of 508.33%.

Algert Global LLC trimmed its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 12.0% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 186,170 shares of the real estate investment trust's stock after selling 25,446 shares during the period. Algert Global LLC's holdings in Healthpeak Properties were worth $3,764,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. TCTC Holdings LLC increased its holdings in Healthpeak Properties by 124.3% in the 1st quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after purchasing an additional 751 shares during the last quarter. Future Financial Wealth Managment LLC acquired a new stake in Healthpeak Properties in the 1st quarter valued at approximately $30,000. S.A. Mason LLC increased its holdings in Healthpeak Properties by 160.9% in the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after purchasing an additional 925 shares during the last quarter. Dagco Inc. acquired a new stake in Healthpeak Properties in the 1st quarter valued at approximately $30,000. Finally, GKV Capital Management Co. Inc. acquired a new stake in Healthpeak Properties in the 1st quarter valued at approximately $36,000. Institutional investors and hedge funds own 93.57% of the company's stock.

Healthpeak Properties Stock Up 2.6%

Shares of Healthpeak Properties stock traded up $0.4450 during trading on Friday, hitting $17.7250. 8,696,799 shares of the stock were exchanged, compared to its average volume of 8,563,543. The firm's 50-day moving average price is $17.62 and its 200 day moving average price is $18.38. The stock has a market cap of $12.32 billion, a price-to-earnings ratio of 73.86, a price-to-earnings-growth ratio of 2.20 and a beta of 1.05. Healthpeak Properties, Inc. has a 12-month low of $16.63 and a 12-month high of $23.26. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The firm had revenue of $694.35 million during the quarter, compared to analysts' expectations of $697.14 million. Healthpeak Properties had a return on equity of 1.85% and a net margin of 5.90%.The firm's revenue was down .2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a dividend, which will be paid on Friday, August 29th. Investors of record on Tuesday, August 19th will be paid a dividend of $0.1017 per share. The ex-dividend date is Monday, August 18th. This represents a yield of 705.0%. Healthpeak Properties's payout ratio is presently 508.33%.

Insider Activity at Healthpeak Properties

In other news, CEO Scott M. Brinker bought 1,490 shares of the firm's stock in a transaction that occurred on Monday, August 4th. The stock was purchased at an average cost of $16.83 per share, with a total value of $25,076.70. Following the transaction, the chief executive officer directly owned 211,906 shares in the company, valued at $3,566,377.98. This trade represents a 0.71% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Tommy G. Thompson bought 5,777 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The stock was purchased at an average cost of $17.27 per share, with a total value of $99,768.79. Following the completion of the transaction, the director owned 144,290 shares in the company, valued at approximately $2,491,888.30. This trade represents a 4.17% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have purchased 14,560 shares of company stock valued at $249,898. 0.23% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research firms recently weighed in on DOC. Morgan Stanley dropped their target price on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a report on Friday. Wall Street Zen downgraded shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Monday, July 7th. Wedbush cut their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. Robert W. Baird set a $21.00 target price on shares of Healthpeak Properties and gave the stock an "outperform" rating in a research note on Wednesday, July 30th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and issued a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a report on Wednesday. Seven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, Healthpeak Properties has a consensus rating of "Moderate Buy" and an average target price of $21.70.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.